Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		2008-0059: Phase I/II study of sorafenib with radiation and temozolomide in newly diagnosed glioblastoma or gliosarcoma

		Phase:		Phase 1/2

		Treatment ID#:		1898 2008-0059

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Prior Surgery is Allowed Prior Radiation is Not Allowed Prior Chemotherapy is Sometimes Allowed newly diagnosed glioblastoma or gliosarcoma

		Last Updated:		03/29/2010

		Tumor Types:		Glioblastoma Multiforme Gliosarcoma


		Comments:		Sorafenib is a multi-functional small molecule inhibitor that targets both the Raf/MAP kinase pathway and VEGF receptors. Study includes tumor tissue analyses for tumor profiling.

		Treatment Type:		Chemotherapy Radiation Immunological, Biological or Targeted Therapy

		Contact:		Jan Esenwein Program Coordinator, Brain Tumor Program MD Anderson Cancer Center 1515 Holcombe Blvd Houston, TX 77030- USA Phone: (713)745-2264 Fax: (713)794-4999 E-mail: jesenwei@mdanderson.org Website: www.mdanderson.org/diseases/braincancer/

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2010 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By